FundWatcher

Compare fund portfolios

See how two funds' portfolios overlap. Enter two tickers:

vs

SBIO vs LABU

Shared holdings
47
SBIO covered by LABU
22.69%
LABU covered by SBIO
22.69%

Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; ● = held by both — hover a shared position to highlight it in both columns.

SBIO (Feb. 28, 2026)

SecurityWeight
KYMERA THERAPEUTICS INC4.66%●
CELCUITY INC3.34%●
ALKERMES PLC3.21%●
CG ONCOLOGY INC3.06%●
MIRUM PHARMACEUTICALS INC3.06%●
AMICUS THERAPEUTICS INC2.86%
ACADIA PHARMACEUTICALS INC2.68%●
NEWAMSTERDAM PHARMA CO NV COMMON STOCK2.60%
CRINETICS PHARMACEUTICALS INC2.52%
APOGEE THERAPEUTICS INC2.48%●
VIKING THERAPEUTICS INC2.47%●
STRUCTURE THERAPEUTICS INC ADR2.47%
XENON PHARMACEUTICALS INC2.16%
SPYRE THERAPEUTICS INC2.15%●
EDGEWISE THERAPEUTICS INC2.08%
TARSUS PHARMACEUTICALS INC2.07%
DENALI THERAPEUTICS INC2.01%●
IDEAYA BIOSCIENCES1.82%●
TRAVERE THERAPEUTICS INC1.72%●
APELLIS PHARMACEUTICALS INC1.71%●
VERA THERAPEUTICS INC1.68%●
DISC MEDICINE INC1.62%●
DIANTHUS THERAPEUTICS INC1.53%●
MINERALYS THERAPEUTICS INC1.49%●
GALAPAGOS GENOMICS NV SPON AR1.42%
MAZE THERAPEUTICS INC1.42%
ZAI LAB LTD UNSPNRD ADR1.39%
STOKE THERAPEUTICS INC1.34%●
NUVATION BIO INC1.31%
CELLDEX THERAPEUTICS INC1.29%●
OLEMA PHARMACEUTICALS INC1.23%●
PHARVARIS NV COMMON STOCK EUR.121.17%
VERICEL CORP1.16%●
RELAY THERAPEUTICS INC1.15%●
TYRA BIOSCIENCES INC1.15%●
AGIOS PHARMACEUTICALS INC1.14%●
SAREPTA THERAPEUTICS INC1.13%●
OCULIS HOLDING AG1.09%
AMYLYX PHARMACEUTICALS INC1.08%
ORUKA THERAPEUTICS INC1.08%●
NOVAVAX INC1.06%●
Immunocore Holdings plc ADS1.05%
SIONNA THERAPEUTICS INC1.05%●
PALVELLA THERAPEUTICS INC1.03%●
MBX BIOSCIENCES INC0.94%
ZENAS BIOPHARMA INC0.91%●
IMMATICS NV COMMON STOCK0.89%
RAPPORT THERAPEUTICS INC0.89%
CORVUS PHARMACEUTICALS INC0.88%●
TAYSHA GENE THERAPIES INC0.80%●

LABU (April 30, 2026)

SecurityWeight
DREYFUS GOVT CASH MGMT FUND7.43%
US ULTRA BOND CBT Sep257.26%
GOLDMAN FINL SQ TRSRY INST 5066.27%
GOLDMAN SACHS FIN GOV 465 INSTITUT1.71%
APELLIS PHARMACEUTICALS INC1.44%●
REVOLUTION MEDICINES INC1.27%
TRAVERE THERAPEUTICS INC1.25%●
ARROWHEAD PHARMACEUTICALS INC1.11%
TWIST BIOSCIENCE CORP1.10%
SUMMIT THERAPEUTICS INC1.09%
ALKERMES PLC1.07%●
TG THERAPEUTICS INC1.06%
MADRIGAL PHARMACEUTICALS INC1.06%
BEAM THERAPEUTICS INC1.02%
APOGEE THERAPEUTICS INC0.98%●
SCHOLAR ROCK HOLDING CORP0.95%
PRAXIS PRECISION MEDICINES INC0.95%
EXELIXIS INC0.94%
MIRUM PHARMACEUTICALS INC0.93%●
UNITED THERAPEUTICS CORP DEL0.92%
NATERA INC0.92%
CELCUITY INC0.92%●
CRISPR Therapeutics A.G. Series A0.92%
KRYSTAL BIOTECH INC0.91%
PROTAGONIST THERAPEUTICS INC0.90%
NEUROCRINE BIOSCIENCES INC0.89%
INCYTE CORP0.89%
CG ONCOLOGY INC0.89%●
CYTOKINETICS INC0.89%
NUVALENT INC-A0.88%
IONIS PHARMACEUTICALS INC0.88%
BRIDGEBIO PHARMA INC0.88%
VAXCYTE INC0.88%
KYMERA THERAPEUTICS INC0.88%●
BIOGEN INC0.87%
COGENT BIOSCIENCES INC0.87%
PTC THERAPEUTICS INC0.87%
INSMED INC0.86%
ALNYLAM PHARMACEUTICALS INC0.85%
ROIVANT SCIENCES0.85%
HALOZYME THERAPEUTICS INC0.84%
ARCUTIS BIOTHERAPEUTICS INC0.83%
SPYRE THERAPEUTICS INC0.83%●
SOLENO THERAPEUTICS INC0.82%
ABBVIE INC0.82%
AMGEN INC0.81%
REGENERON PHARMACEUTICALS INC0.80%
ULTRAGENYX PHARMA INC0.80%
ACADIA PHARMACEUTICALS INC0.80%●
RHYTHM PHARMACEUTICALS INC0.80%

Machine-readable: JSON · Markdown. Programmatic access via the agent surface.